Bristol Myers Squibb (BMY) reported strong Q4 earnings earlier in February, and prospects remain strong for 2025, although it may…
Bristol Myers Squibb (BMY) reported strong Q4 earnings earlier in February, and prospects remain strong for 2025, although it may…
Utilities enter top 5 Last week’s trading, especially the sell-off on Friday, has caused the Utilities sector to enter the…